2021
DOI: 10.1042/bsr20210174
|View full text |Cite
|
Sign up to set email alerts
|

Antibody microarray analysis of the amniotic fluid proteome for predicting the outcome of rescue cerclage in patients with cervical insufficiency

Abstract: Little is known about the biomarkers that can identify patient candidates suitable for rescue cerclage procedure. The purpose of the study was to identify novel biomarkers in amniotic fluid (AF) that can predict the outcome of rescue cerclage in patients with cervical insufficiency by using an antibody microarray. This case-control study was conducted using AF samples collected from singleton pregnant women who underwent rescue cerclage following a diagnosis of cervical insufficiency (19–25 weeks). Patients we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 43 publications
1
4
1
Order By: Relevance
“…43 In the setting of rescue cerclage, asymptomatic short cervix and CI, and PTL, previous studies on AF showed that MIP-1α levels are significantly increased in patients with SPTB or intra-amniotic infection/inflammation compared with those without these conditions, which is consistent with the biological functions of MIP-1α. [44][45][46][47][48] Contrary to previous reports on AF samples, the present study unexpectedly demonstrates for the first time that MIP-1α levels are significantly decreased in the plasma of women with SPTB after cerclage. Nevertheless, this finding is quite evident and supported by previous studies demonstrating (1) a significantly decreased level of plasma MIP-1α in PTL women with SPTB 29 ; and…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…43 In the setting of rescue cerclage, asymptomatic short cervix and CI, and PTL, previous studies on AF showed that MIP-1α levels are significantly increased in patients with SPTB or intra-amniotic infection/inflammation compared with those without these conditions, which is consistent with the biological functions of MIP-1α. [44][45][46][47][48] Contrary to previous reports on AF samples, the present study unexpectedly demonstrates for the first time that MIP-1α levels are significantly decreased in the plasma of women with SPTB after cerclage. Nevertheless, this finding is quite evident and supported by previous studies demonstrating (1) a significantly decreased level of plasma MIP-1α in PTL women with SPTB 29 ; and…”
Section: Discussioncontrasting
confidence: 99%
“…MIP‐1α, also known as chemokine ligand 3, is a chemotactic chemokine that is mainly produced by activated monocytes/macrophages and plays an important role in immune and inflammatory responses 43 . In the setting of rescue cerclage, asymptomatic short cervix and CI, and PTL, previous studies on AF showed that MIP‐1α levels are significantly increased in patients with SPTB or intra‐amniotic infection/inflammation compared with those without these conditions, which is consistent with the biological functions of MIP‐1α 44–48 . Contrary to previous reports on AF samples, the present study unexpectedly demonstrates for the first time that MIP‐1α levels are significantly decreased in the plasma of women with SPTB after cerclage.…”
Section: Discussionsupporting
confidence: 72%
“…The patients were excluded if they had (ⅰ) prophylactic cerclage during early pregnancy; (ⅱ) preterm labor syndrome or rupture of membranes at the diagnosis; (ⅲ) multiple pregnancies; (ⅳ) clinical chorioamnionitis at presentation; and (ⅴ) major congenital anomalies. A subset of participants in the present study was included in the previous studies, which showed the value of biomarkers for cerclage failure prediction using microarray and proteomic analyses [ 6 , 13 , 15 ]. A clinical diagnosis of acute CI was made when the intact fetal membranes were visible at the level of the external os or when they protruded into the vagina, as confirmed by sterile speculum examination with mid-trimester painless cervical dilation (≥ 1 cm).…”
Section: Methodsmentioning
confidence: 99%
“…The stored AF samples were assayed using commercial ELISA kits for endoglin, endostatin, haptoglobin, IGFBP-3, -4, IL-6, kallistatin, lumican, macrophage colony-stimulating factor (M-CSF), PTX3, p-selectin, RAGE, resistin, transforming growth factor-beta-induced (TGFBI), and vitamin D-binding protein (VDBP) (DuoSet ELISA; R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions. These proteins were chosen for the study because they are important regulators of inflammation, angiogenesis, and extracellular matrix–related and immune responses ( https://www.uniprot.org/ ); they are potential AF biomarkers for identifying patients with acute CI at high risk of SPTD after emergency cerclage based on our previous studies and other reports [ 13 , 21 , 28 34 ]; little information is currently available regarding their altered expression in AF associated with poor pregnancy outcomes after emergency cerclage; and an appropriate ELISA kit was commercially available. IL-6 levels were assayed in the AF for comparison with potential biomarkers assessed in this study, as it is a prototype marker for rescue cerclage failure [ 4 , 6 , 17 , 35 ].…”
Section: Methodsmentioning
confidence: 99%
“…Infections considered were gonorrhea, syphilis, chlamydia, hepatitis B, hepatitis C, and GBS. The de nition of cervical insu ciency includes three criteria: painless cervical dilation of 1 cm or more, exposed or bulging fetal membranes without uterine contractions as visually determined using a sterile speculum, or cervical length equal to or less than 25mm before 24 weeks of gestation [17]. Thyroid dysfunction abnormalities was identi ed based on self-reported physician diagnosis of hyperthyroidism or hypothyroidism, or the use of antithyroid drugs.…”
Section: Predictor Variablesmentioning
confidence: 99%